Deutsche Bank’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Buy |
928,766
+4,492
| +0.5% | +$50K | ﹤0.01% | 984 |
|
|
2025
Q1 | $11.4M | Buy |
924,274
+511,662
| +124% | +$6.29M | ﹤0.01% | 973 |
|
|
2024
Q4 | $4.62M | Buy |
412,612
+356
| +0.1% | +$3.98K | ﹤0.01% | 1360 |
|
|
2024
Q3 | $2.87M | Sell |
412,256
-241,429
| -37% | -$1.68M | ﹤0.01% | 1530 |
|
|
2024
Q2 | $4.94M | Buy |
+653,685
| New | +$4.94M | ﹤0.01% | 1242 |
|
|
2022
Q2 | – | Sell |
-3,857
| Closed | -$32K | – | 4071 |
|
|
2022
Q1 | $32K | Sell |
3,857
-460
| -11% | -$3.82K | ﹤0.01% | 3853 |
|
|
2021
Q4 | $44K | Buy |
4,317
+230
| +6% | +$2.34K | ﹤0.01% | 3869 |
|
|
2021
Q3 | $65K | Sell |
4,087
-46
| -1% | -$732 | ﹤0.01% | 3937 |
|
|
2021
Q2 | $98K | Buy |
+4,133
| New | +$98K | ﹤0.01% | 4057 |
|